Zingerone (ZGR), a phenolic alkanone found in Zingiber officinale, has been reported to have various pharmacological activities including anti-inflammatory and anti-apoptotic activities. The endothelial cell protein C receptor (EPCR) plays an important role in the cytoprotective pathway and activation of protein C. EPCR can be shed from the cell surface, which is mediated by tumor necrosis factor-α converting enzyme (TACE). However, little is known about the effects of ZGR on EPCR shedding. We investigated this by monitoring the effects of ZGR on phorbol-12-myristate 13-acetate (PMA)-, tumor necrosis factor (TNF)-, and interleukin (IL)-1-induced EPCR shedding in human umbilical vein endothelial cells (HUVECs), and cecal ligation and puncture (CLP)-mediated EPCR shedding in mice, as well as by analyzing the underlying mechanisms. Here, ZGR triggered potent inhibition of PMA-, TNF-α-, IL-1-and CLP-induced EPCR shedding through the inhibition of phosphorylation of mitogen-activated protein kinases (MAPKs) such as p38, janus kinase (JNK), and extracellular signal-regulated kinase (ERK) 1/2. ZGR also inhibited PMA-induced TACE expression and activity in HUVECs, suggesting that p38, ERK1/2, and JNK could be molecular targets of ZGR. These results demonstrate the potential of ZGR as an agent against PMA-and CLP-mediated EPCR shedding.
A soluble form of endothelial cell protein C receptor (sEPCR) can be generated through proteolytic cleavage by metalloprotease activity, which is inducible by inflammatory mediators [1] [2] . This process is known as EPCR shedding. sEPCR circulates in plasma, retaining its ability to bind protein C (PC) and activated PC (APC), but does not enhance PC activation [3] . It inhibits the anticoagulant activity of APC by forming a complex that does not bind to phospholipid membranes [4] . Owing to the shedding of membrane EPCR, sEPCR can be detected in plasma at approximately 100 ng/mL. Moreover, high levels of sEPCR have been reported in sepsis [5] . Previous studies have reported a dramatic increase in EPCR shedding from the endothelium induced by various inflammatory mediators, (interleukin (IL)-1 or phorbolmyristate acetate), and thrombin, and the EPCR shedding is potentiated by the microtubule disrupting agent, nocodazole [1] [2] 6] . And, the phosphorylation of p38 MAPK, ERK1/2, and JNK was increased by stimulation with phorbol-12-myristate 13-acetate (PMA) [7] [8] [9] .
Zingiber officinale is used as a natural dietary spice and has potent anti-inflammatory, anti-oxidative, and anti-cancer properties [10] . Zingerone (ZGR) is a stable active component in dry ginger rhizome [11] and has been reported to exhibit various pharmacological activities such as anti-inflammatory, antiapoptotic, and protective activities against myocardial infarction and irritable bowel disorder [12] [13] [14] [15] . During screening for anti-EPCR shedding effect of natural products, ZGR strongly inhibited EPCR shedding in human umbilical vein endothelial cells (HUVECs). Although ZGR has been reported to have diverse biological activities, its effects on EPCR shedding have not yet been studied. Therefore, in the current study, we investigated the effects of ZGR on PMA-induced EPCR shedding in human endothelial cells and in a cecal ligation and puncture (CLP) model of septicemia in mice. Previous studies have demonstrated the PMA-induced EPCR shedding in HUVECs [16] [17] [18] [19] . In agreement with these studies, our results showed that 1 M PMA fully stimulated EPCR shedding in HUVECs ( Figure 1A ) and decreased membrane EPCR in HUVECs ( Figure 1B) . To investigate the effects of ZGR on PMA-mediated EPCR shedding, HUVECs were pretreated with 50 M ZGR, followed by stimulation with 1 M PMA for 1 h. ZGR inhibited EPCR shedding induced by PMA in HUVECs, with an optimal effect at 10-50 M ( Figure 1A, B) . To confirm the inhibitory effects of ZGR on EPCR shedding, TNF- or IL-1 was used as previous studies have shown that EPCR shedding was induced by TNF-α in HUVECs [7, [18] [19] . We found that EPCR shedding was induced by TNF- or IL-1, and ZGR suppressed TNF--mediated or IL-1-mediated EPCR shedding ( Figure 1A , B) in HUVECs. TNF-α and IL-1β have been shown to be important mediators of endotoxemia [20] [21] ; therefore, the current findings showing that ZGR inhibited TNF--mediated EPCR shedding could support the notion that ZGR has anti-inflammatory effects in human endothelial cells. A previous study reported that PMA-stimulated EPCR shedding is mediated by TACE [17] [18] [19] . To determine whether ZGR could inhibit PMA-stimulated TACE expression and activity, cells were pretreated with increasing concentrations of ZGR for 6 h, followed by stimulation with 1 M PMA for 1 h. Data show that treatment with ZGR resulted in the inhibition of PMA-induced TACE expression in endothelial cells at both protein (Figure 2A , B) and transcription (mRNA expression, Figure 2C ) levels. The activity of PMA-induced TACE in endothelial cells was also reduced by ZGR ( Figure 2D ).
In experiments to confirm the inhibitory effects of ZGR on EPCR shedding in vivo, a CLP-induced septic mouse model was used, as it closely resembles sepsis in humans [22] [23] [24] . To examine the trend in mortality caused by CLP, groups of septic and sham-operated mice were monitored for survival for 132 h (>5 days). The survival rate of mice subjected to CLP was 40% at 80 h and 0% at 100 h after the operation ( Figure 3A) . In CLP-induced septic mice, immunohistochemical analysis demonstrated decreased expression of membrane EPCR compared with the control (Figure 3B ). The administration of ZGR (0.36 or 0.72 mg/kg) at 12 h after CLP did not prevent CLP-induced EPCR shedding in mice ( Figure 3C ). Therefore, ZGR was administered twice (once at 12 h, then at 50 h after CLP), which resulted in a decrease in EPCR shedding ( Figure  3D ). The average circulating blood volume for mice is 72 mL/kg [25] . As the average weight of these mice was 27 g and the average blood volume was 2 mL, the amount of ZGR (0.36 or 0.72 mg/kg) injected yielded a maximum concentration of 25 M or 50 M in the peripheral blood. Based on these findings, we hypothesized that the treatment with ZGR would reduce CLP-induced sepsis lethality. The administration of ZGR (once at 12 h, then at 50 h after CLP) resulted in an increase in the survival rate to 30-60% according to Kaplan-Meier survival analysis (p < 0.0001, Figure 3A ). This marked benefit achieved by the administration of ZGR suggests that the inhibition of EPCR shedding provides a therapeutic strategy for the management of sepsis. The PC pathway is a negative feedback mechanism that regulates coagulation [26] [27] . The main player in this pathway is APC, which proteolytically cleaves FVa and FVIIIa to arrest thrombin generation and subsequent fibrin formation [26] [27] . The inactive zymogen PC is converted to APC by the binding of thrombin; this activation is augmented more than 1000-fold when thrombin binds to its receptor, thrombomodulin, and a further 10-20-fold when PC binds to EPCR [26] [27] . Therefore, we tested the effects of ZGR on PC concentration. The data showed that plasma PC levels were significantly attenuated in CLP-operated mice and the administration of ZGR suppressed the CLP-induced decrease in PC levels ( Figure 3E) . And, the activation of the coagulation cascade appeared to be an essential component in the development of multi-organ failure in sepsis [28] . Therefore, we tested the effects of ZGR on thrombin generation in HUVECs. Pre-incubation of HUVECs with FVa and FXa in the presence of CaCl 2 before the addition of prothrombin resulted in the production of thrombin ( Figure 3F ). In addition, treatment with ZGR resulted in a dosedependent inhibition of thrombin production from prothrombin ( Figure 3F ).
Previous studies have reported the involvement of p38 MAPK, ERK1/2, and JNK in cytokine-induced EPCR shedding, and increased phosphorylation of p38 MAPK, ERK1/2, and JNK has been known to occur through PMA stimulation [7] [8] [9] . Therefore, to determine the molecular mechanisms and molecular targets underlying the suppression of PMA-induced EPCR shedding by ZGR, the effects of ZGR on the PMA-stimulated phosphorylation of p38 MAPK, ERK1/2, and JNK were tested. As shown in Figure  4A -C, treatment with ZGR resulted in a reduction in PMAstimulated phosphorylation of p38 MAPK ( Figure 4A ), ERK1/2 ( Figure 4B ), and JNK ( Figure 4C) . A panel of pharmacological inhibitors of MAP kinases was used to confirm the involvement of MAPK in EPCR shedding. As shown in Figure 4D , a distinct attenuation of sEPCR release in HUVECs was observed after treatment with PD-98059 (a pharmacological inhibitor of ERK 1/2 activity), SB-203580 (an inhibitor of p38 MAPK), and SP-600125 (an inhibitor of JNK). We also found synergistic anti-EPCR shedding effects of each MAP kinase inhibitor on the PMAmediated EPCR shedding with ZGR ( Figure 4D ).
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Natural Product Communications Vol. 12 (10) 2017 1625 As the increased phosphorylation of p38 MAPK, ERK1/2, and JNK is known to occur through PMA stimulation [7] [8] [9] and the activation of TACE occurs upon activation of ERK or p38 MAPK [10] [11] , we aimed to determine the mechanisms underlying the inhibition of PMA-stimulated EPCR shedding and expression of TACE by ZGR. For this, we investigated the involvement of MAPK signaling pathways under PMA-stimulated conditions. Three major classes of MAPKs are represented by ERK 1/2 and the stress-activated protein kinase families JNK and p38 MAPK. As shown in Figures 2 and 4 , ZGR inhibited the responses of PMA-stimulated expression of TACE and phosphorylation of p38 MAPK, ERK1/2, and JNK. Therefore, ZGR inhibited EPCR shedding through the inhibition of the PMA-stimulated expression of TACE and the activation of MAPKs, which suggested that p38, ERK1/2, and JNK could be molecular targets of ZGR.
Collectively, the results of this study show that ZGR potently inhibited PMA-, TNF--, IL-1β- and CLP-induced EPCR shedding and suppressed the expression and activity of TACE. ZGR also suppressed the CLP-induced PC reduction in mice and thrombin generation in HUVECs. In addition, ZGR reduced PMA-stimulated phosphorylation of p38 MAPK, ERK 1/2, and JNK. TACE induced the shedding of numerous cell membrane-bound proteins, and in the present study, EPCR shedding was shown to be mediated by TACE, which was inhibited by ZGR. Selective targeting and inhibition of sEPCR by ZGR in the endothelium against several inducers, such as PMA, TNF-, IL-1 and CLP, hold promise in the treatment of severe vascular inflammatory diseases such as sepsis. In addition, we suggest that p38, ERK 1/2, and JNK are possible molecular targets of ZGR and responsible for the anti-EPCR shedding effects of ZGR. Although the use of ZGR for therapeutic purposes could have non-specific effects, the data presented in this study provide novel information on the role of ZGR in EPCR shedding. Therefore, our findings indicate the potential of ZGR as a candidate in the treatment of severe vascular inflammatory diseases, such as sepsis and septic shock.
Experimental
Reagents: ZGR, anisomycin, and IL-1 were purchased from Sigma-Aldrich (St. Louis, MO). sEPCR and TNF- were purchased from Abnova (Taiwan). FVa, FXa, prothrombin, and thrombin were obtained from Haematologic Technologies (Essex Junction, VT).
Cell culture: Primary HUVECs were obtained from Cambrex Bio Science (Charles City, IA) and maintained as previously described [19, [29] [30] .
ELISA:
To determine the expression levels of EPCR in HUVECs, modified whole-cell enzyme-linked immunosorbent assay (ELISA) was performed as previously described [18] [19] . In brief, confluent monolayers of HUVECs were treated with or without ZGR for 6 h and then with PMA, TNF-, or IL-1 for 1 h.
Immunohistochemistry:
To analyze the expression pattern of EPCR, the descending thoracic aortic vessels from CLP-induced septic (Day 4) and sham-operated mice were removed, and the EPCR was stained as previously described [6, [18] [19] .
ELISA for expression analysis of total and phosphorylated p-38 MAPK, ERK1/2, and JNK: HUVECs were cultured in 96-well microplates for quantifying p38 MAPK, ERK1/2, and JNK phosphorylation. On the day of the experiments, culture medium was replaced with serum-free growth medium. Cells were treated with or without ZGR for 6 h and then with PMA (1M) for 1 h. The activation of p38 MAPK, ERK 1/2, and JNK was quantified in nuclear lysates using ELISA kits for total/phosphorylated p38 MAPK (Invitrogen, Carlsbad, CA, for total p38 MAPK and Cell Signaling Technology, Danvers, MA, for phosphorylated-p38 MAPK) and total/phospho ERK1/2 and JNK (R&D Systems, Minneapolis, MN) according to the manufacturer's instructions.
TACE activity assay:
For the TACE activity assay, a commercially available TACE activity kit (Innozyme TACE activity assay kit, EMD Millipore, Billerica, MA) was used as previously described [6] .
Thrombin production on the surface of HUVECs: The measurement of thrombin production by HUVECs was quantified as previously described [31] .
Competitive ELISA for sEPCR and TACE: The concentrations of sEPCR and TACE were measured as previously described [6] .
Western blotting: Confluent monolayers of HUVECs were treated with or without ZGR for 6 h and then with PMA for 1 h. Total cell extracts were prepared by lysing the cells. The protein concentration was determined using Bradford assay. Equal amounts of proteins were separated by SDS-PAGE (10%) and electroblotted overnight onto Immobilon membranes (Millipore, Billerica, MA). The membranes were blocked for 1 h with 5% low-fat milk-powder TBS (50 mMTris-HCl, pH 7.5, 150 mMNaCl) containing 0.05% Tween 20 and incubated with anti-TACE antibodies (Santa Cruz, Dallas, TX) at room temperature for 1.5 h. They were further incubated with horseradish-peroxidase-conjugated secondary antibody and ECL detection according to the manufacturer's instructions.
RNA isolation and real-time quantitative RT-PCR:
Confluent monolayers of HUVECs were treated with or without ZGR for 6 h and then with PMA for 1 h. RNA was isolated using TRI-Reagent (Invitrogen, Grand Island, NY) according to the manufacturer's instructions and PT-PCR was conducted as described previously [6] . (SD). The statistical significance of differences between test groups was evaluated using SPSS for Windows, version 16.0 (SPSS, Chicago, IL). Statistical relevance was determined by one-way analysis of variance (ANOVA) and Tukey's post-test. P values less than 0.05 were considered statistically significant. Survival analysis of CLP-induced sepsis outcomes was performed using KaplanMeier analysis.
